American National Bank & Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History

American National Bank & Trust’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.23K	Sell	5 -3	-38%	-$763	﹤0.01%	594
2026 Q2	$2.41K	Buy	+8	New	+$2.41K	﹤0.01%	585
2026 Q1	–	Sell	-6	Closed	-$2.39K	–	621
2025 Q4	$2.39K	Buy	+6	New	+$2.65K	﹤0.01%	630
2023 Q2	–	Sell	-66	Closed	-$13.2K	–	577
2023 Q1	$13.2K	Buy	+66	New	+$13.9K	﹤0.01%	377
2022 Q4	–	Sell	-11	Closed	-$2K	–	621
2022 Q3	$2K	Buy	+11	New	+$2.1K	﹤0.01%	486

Other funds holding ALNY

MSV

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

LJHT

Laurie J. Hall Trustee $314M AUM 27.43% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

CPBTD

Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

BFS

Burkett Financial Services Rock Hill, South Carolina $331M AUM 14.93% 1-Year Est. Return

American National Bank & Trust's ALNY Position: Q3 2026 in Review

American National Bank & Trust reduced its Alnylam Pharmaceuticals (ALNY) stake by 38% in Q3 2026, selling an estimated $763 and leaving 5 shares worth $1.23K. The position accounts for ﹤0.01% of the portfolio, ranked #594.

American National Bank & Trust first reported a position in ALNY in Q3 2022 and has held it in 5 quarters since. The position peaked at $13.2K in Q1 2023. 19 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

American National Bank & Trust held 5 shares of Alnylam Pharmaceuticals worth $1.23K as of Q3 2026.
American National Bank & Trust sold 3 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $763.
Alnylam Pharmaceuticals made up ﹤0.01% of American National Bank & Trust's portfolio in Q3 2026, its #594 holding.
American National Bank & Trust first reported a position in Alnylam Pharmaceuticals in Q3 2022 and has held it in 5 quarters since.
American National Bank & Trust's Alnylam Pharmaceuticals position peaked at $13.2K in Q1 2023.
19 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on American National Bank & Trust's 13F filing for Q3 2026, filed 7 Oct 2026.